Key details
Sponsor
University of Tasmania
Collaborators
National Health and Medical Research Council, Australia, University of Sydney
Enrollment target
~3,000 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years and older
Last updated October 2023